VYGR (Voyager Therapeutics, Inc.) is set to announce its Q2'26 results on July 30, time not specified. The earnings are expected to be disclosed at 8:00 AM ET (12:00 PM UTC).
For Q2'26, revenue estimate is 4.56 million USD with EPS (earnings per share) anticipated at (0.50) USD. Learn more details at .
Revenue & EPS values are provided in USD
| Q2'25Q3'25Q4'25Q1'26Q2'26 | |||||
| Revenue Reported5.20 M13.37 M15.34 M2.59 M— | Revenue Estimate9.91 M7.86 M10.49 M8.79 M4.56 M | Revenue Surprise-47.51%+70.00%+46.17%-70.49% | EPS Reported(0.57)(0.47)(0.46)(0.47) | EPS Estimate(0.53)(0.52)(0.51)(0.55)(0.50) | EPS Surprise-8.45%+9.77%+9.90%+14.68% |